Toribio M L, De Landázuri M O, López-Botet M
Eur J Immunol. 1983 Dec;13(12):964-9. doi: 10.1002/eji.1830131203.
Supernatants containing interleukin 2 (IL 2) induce strong proliferation and expression of natural killer (NK)-like activity in human thymocytes. Different supernatants were compared for: (a) IL 2 activity, (b) thymocyte proliferation capacity and (c) induction of NK-like cytotoxicity. All these activities were present in a partially purified IL2 preparation obtained by gel filtration chromatography (Mr 15 000-20 000). However, in supernatants from different sources and in the 15 000-20 000-Mr semipurified fractions, we observed that the NK-like cytotoxicity inducer effect did not correlate with either the mitogenicity or the IL2 activity. The presence in the supernatants of interleukin 1 (IL 1), interferon (IFN) or phytohemagglutinin (PHA) does not seem to be a prerequisite for the induction of NK-like cytotoxicity, since this activity was (a) fully present in supernatants devoid of IL 1, IFN and PHA, (b) absent in preparations of IL 1 and (c) not augmented after supplementation of the supernatants with IFN-gamma. We also investigated the cellular characteristics of the precursor thymocytes responsive to IL 2 supernatants. Removal of the T3+ cells at the initiation of the culture abrogated the proliferative response and eliminated the generation of NK-like cytotoxicity. Under the same conditions, removal of the HTA1+ population increased the proliferation and did not affect the NK-like activity. Our results suggest that: (a) either IL 2 is not responsible for the induction of NK-like cytotoxicity or its action is modulated by other molecules, and (b) the precursor-responder population is preferentially included in the mature T3+ subset.
含有白细胞介素2(IL-2)的上清液可诱导人胸腺细胞强烈增殖并表达自然杀伤(NK)样活性。对不同的上清液进行了以下比较:(a)IL-2活性,(b)胸腺细胞增殖能力,以及(c)NK样细胞毒性的诱导。所有这些活性都存在于通过凝胶过滤色谱法获得的部分纯化的IL-2制剂中(分子量15000 - 20000)。然而,在来自不同来源的上清液以及分子量为15000 - 20000的半纯化组分中,我们观察到NK样细胞毒性诱导效应与促有丝分裂活性或IL-2活性均不相关。上清液中白细胞介素1(IL-1)、干扰素(IFN)或植物血凝素(PHA)的存在似乎并非诱导NK样细胞毒性的先决条件,因为这种活性(a)在不含IL-1、IFN和PHA的上清液中完全存在,(b)在IL-1制剂中不存在,并且(c)在上清液补充γ干扰素后并未增强。我们还研究了对IL-2上清液有反应的前体胸腺细胞的细胞特征。在培养开始时去除T3 +细胞消除了增殖反应并消除了NK样细胞毒性的产生。在相同条件下,去除HTA1 +群体增加了增殖且不影响NK样活性。我们的结果表明:(a)要么IL-2不负责诱导NK样细胞毒性,要么其作用受到其他分子的调节,并且(b)前体反应细胞群体优先包含在成熟的T3 +亚群中。